Ethmozine

Active Ingredient(s): Moricizine
FDA Approved: * June 19, 1990
Pharm Company: * SHIRE
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ethmozine Overview

Moracizine[1] or moricizine, sold under the trade name Ethmozine, is an antiarrhythmic of class IC.[2] It was used for the prophylaxis and treatment of serious and life-threatening ventricular arrhythmias,[3] but was withdrawn in 2007 for commercial reasons.[4] Pharmacology Moracizine, a phenothiazine derivative, undergoes extensive first-pass metabolism and is also extensively metabolized after it has entered the circulation....

Read more Ethmozine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Moracizine

Recent Ethmozine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Ethmozine: (3 results)

Sorted by National Drug Code

• 54092-046 Ethmozine 200 mg Oral Tablet by Shire Us Inc.
• 54092-047 Ethmozine 250 mg Oral Tablet by Shire Us Inc.
• 54092-048 Ethmozine 300 mg Oral Tablet by Shire Us Inc.

Other drugs which contain Moricizine or a similar ingredient: (1 result)

• MORICIZINE

Related Ethmozine Topics: